CA Stock MarketDetailed Quotes

DRUG Bright Minds Biosciences Inc

Watchlist
  • 58.370
  • +2.860+5.15%
15min DelayMarket Closed Dec 13 15:13 ET
407.10MMarket Cap-66.33P/E (TTM)

Bright Minds Biosciences Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Jun 30, 2024
(Q2)Mar 31, 2024
(Q1)Dec 31, 2023
(FY)Sep 30, 2023
(Q4)Sep 30, 2023
(Q3)Jun 30, 2023
(Q2)Mar 31, 2023
(Q1)Dec 31, 2022
(FY)Sep 30, 2022
(Q4)Sep 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-116.21%-234.74K
-72.83%558.06K
-26.08%1.7M
-50.68%7.39M
-47.33%1.59M
-45.61%1.45M
-54.12%2.05M
-52.36%2.3M
70.44%14.98M
1.50%3.01M
Selling and administrative expenses
-15.69%320.64K
-35.38%363.6K
-49.71%401.18K
-13.77%2.2M
6.57%459.16K
-36.96%380.32K
-12.17%562.64K
-8.98%797.69K
11.38%2.55M
-42.16%430.86K
-Selling and marketing expense
--0
--0
-10.88%36.6K
-78.36%119.42K
-50.93%36.6K
-53.69%37.1K
-97.37%4.65K
-81.36%41.07K
-35.24%551.86K
-49.07%74.59K
-General and administrative expense
-6.58%320.64K
-34.84%363.6K
-51.81%364.58K
4.06%2.08M
18.61%422.56K
-34.39%343.22K
20.33%557.99K
15.33%756.62K
39.00%2M
-40.48%356.27K
Research and development costs
-153.94%-566.75K
-92.48%105.18K
-16.04%1.23M
-58.95%5M
-57.06%1.09M
-48.78%1.05M
-62.65%1.4M
-62.04%1.46M
92.92%12.18M
15.08%2.54M
Other operating expenses
-33.88%11.36K
-4.08%89.29K
76.65%72.29K
-23.21%186.65K
-9.37%35.45K
114.56%17.19K
-0.45%93.09K
-60.05%40.92K
33.75%243.08K
189.84%39.12K
Operating profit
116.21%234.74K
72.83%-558.06K
26.08%-1.7M
50.68%-7.39M
47.33%-1.59M
45.61%-1.45M
54.12%-2.05M
52.36%-2.3M
-70.44%-14.98M
-1.50%-3.01M
Net non-operating interest income (expenses)
14.99K
0
0
0
0
Non-operating interest income
--14.99K
----
----
----
----
--0
----
----
----
----
Other net income (expenses)
-96.18%-19.83K
-560.06%-16.08K
139.67%14.73K
39.78%14.19K
15.47%57.93K
-336.51%-10.11K
134.24%3.5K
-8.94%-37.13K
-93.41%10.15K
-49.64%50.17K
Gain on sale of security
-96.18%-19.83K
-560.06%-16.08K
139.67%14.73K
16.77%14.19K
11.05%57.93K
-336.51%-10.11K
134.24%3.5K
-8.94%-37.13K
-92.11%12.15K
-47.64%52.17K
Special income (charges)
----
----
----
--0
----
----
----
----
---2K
----
-Less:Impairment of capital assets
----
----
----
--0
----
----
----
----
--2K
----
Income before tax
115.77%229.9K
72.00%-574.14K
27.88%-1.68M
50.74%-7.37M
48.40%-1.53M
45.14%-1.46M
54.31%-2.05M
51.93%-2.34M
-72.99%-14.96M
-3.28%-2.96M
Income tax
Earnings from equity interest net of tax
Net income
115.77%229.9K
72.00%-574.14K
27.88%-1.68M
50.74%-7.37M
48.40%-1.53M
45.14%-1.46M
54.31%-2.05M
51.93%-2.34M
-72.99%-14.96M
-3.28%-2.96M
Net income continuous operations
115.77%229.9K
72.00%-574.14K
27.88%-1.68M
50.74%-7.37M
48.40%-1.53M
45.14%-1.46M
54.31%-2.05M
51.93%-2.34M
-72.99%-14.96M
-3.28%-2.96M
Noncontrolling interests
Net income attributable to the company
115.77%229.9K
72.00%-574.14K
27.88%-1.68M
50.74%-7.37M
48.40%-1.53M
45.14%-1.46M
54.31%-2.05M
51.93%-2.34M
-72.99%-14.96M
-3.28%-2.96M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
115.77%229.9K
72.00%-574.14K
27.88%-1.68M
50.74%-7.37M
48.40%-1.53M
45.14%-1.46M
54.31%-2.05M
51.93%-2.34M
-72.99%-14.96M
-3.28%-2.96M
Diluted earnings per share
112.82%0.05
75.93%-0.13
32.31%-0.44
67.33%-1.98
60.40%-0.4
65.18%-0.39
71.58%-0.54
68.29%-0.65
-25.73%-6.06
17.21%-1.01
Basic earnings per share
112.82%0.05
75.93%-0.13
32.31%-0.44
67.33%-1.98
60.40%-0.4
65.18%-0.39
71.58%-0.54
68.29%-0.65
-25.73%-6.06
17.21%-1.01
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Jun 30, 2024(Q2)Mar 31, 2024(Q1)Dec 31, 2023(FY)Sep 30, 2023(Q4)Sep 30, 2023(Q3)Jun 30, 2023(Q2)Mar 31, 2023(Q1)Dec 31, 2022(FY)Sep 30, 2022(Q4)Sep 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -116.21%-234.74K-72.83%558.06K-26.08%1.7M-50.68%7.39M-47.33%1.59M-45.61%1.45M-54.12%2.05M-52.36%2.3M70.44%14.98M1.50%3.01M
Selling and administrative expenses -15.69%320.64K-35.38%363.6K-49.71%401.18K-13.77%2.2M6.57%459.16K-36.96%380.32K-12.17%562.64K-8.98%797.69K11.38%2.55M-42.16%430.86K
-Selling and marketing expense --0--0-10.88%36.6K-78.36%119.42K-50.93%36.6K-53.69%37.1K-97.37%4.65K-81.36%41.07K-35.24%551.86K-49.07%74.59K
-General and administrative expense -6.58%320.64K-34.84%363.6K-51.81%364.58K4.06%2.08M18.61%422.56K-34.39%343.22K20.33%557.99K15.33%756.62K39.00%2M-40.48%356.27K
Research and development costs -153.94%-566.75K-92.48%105.18K-16.04%1.23M-58.95%5M-57.06%1.09M-48.78%1.05M-62.65%1.4M-62.04%1.46M92.92%12.18M15.08%2.54M
Other operating expenses -33.88%11.36K-4.08%89.29K76.65%72.29K-23.21%186.65K-9.37%35.45K114.56%17.19K-0.45%93.09K-60.05%40.92K33.75%243.08K189.84%39.12K
Operating profit 116.21%234.74K72.83%-558.06K26.08%-1.7M50.68%-7.39M47.33%-1.59M45.61%-1.45M54.12%-2.05M52.36%-2.3M-70.44%-14.98M-1.50%-3.01M
Net non-operating interest income (expenses) 14.99K0000
Non-operating interest income --14.99K------------------0----------------
Other net income (expenses) -96.18%-19.83K-560.06%-16.08K139.67%14.73K39.78%14.19K15.47%57.93K-336.51%-10.11K134.24%3.5K-8.94%-37.13K-93.41%10.15K-49.64%50.17K
Gain on sale of security -96.18%-19.83K-560.06%-16.08K139.67%14.73K16.77%14.19K11.05%57.93K-336.51%-10.11K134.24%3.5K-8.94%-37.13K-92.11%12.15K-47.64%52.17K
Special income (charges) --------------0-------------------2K----
-Less:Impairment of capital assets --------------0------------------2K----
Income before tax 115.77%229.9K72.00%-574.14K27.88%-1.68M50.74%-7.37M48.40%-1.53M45.14%-1.46M54.31%-2.05M51.93%-2.34M-72.99%-14.96M-3.28%-2.96M
Income tax
Earnings from equity interest net of tax
Net income 115.77%229.9K72.00%-574.14K27.88%-1.68M50.74%-7.37M48.40%-1.53M45.14%-1.46M54.31%-2.05M51.93%-2.34M-72.99%-14.96M-3.28%-2.96M
Net income continuous operations 115.77%229.9K72.00%-574.14K27.88%-1.68M50.74%-7.37M48.40%-1.53M45.14%-1.46M54.31%-2.05M51.93%-2.34M-72.99%-14.96M-3.28%-2.96M
Noncontrolling interests
Net income attributable to the company 115.77%229.9K72.00%-574.14K27.88%-1.68M50.74%-7.37M48.40%-1.53M45.14%-1.46M54.31%-2.05M51.93%-2.34M-72.99%-14.96M-3.28%-2.96M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders 115.77%229.9K72.00%-574.14K27.88%-1.68M50.74%-7.37M48.40%-1.53M45.14%-1.46M54.31%-2.05M51.93%-2.34M-72.99%-14.96M-3.28%-2.96M
Diluted earnings per share 112.82%0.0575.93%-0.1332.31%-0.4467.33%-1.9860.40%-0.465.18%-0.3971.58%-0.5468.29%-0.65-25.73%-6.0617.21%-1.01
Basic earnings per share 112.82%0.0575.93%-0.1332.31%-0.4467.33%-1.9860.40%-0.465.18%-0.3971.58%-0.5468.29%-0.65-25.73%-6.0617.21%-1.01
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Price
% Chg

No Data